In early findings presented by University of Windsor researchers, black maitake (Grifola frondosa) extract triggered strong dose-dependent apoptosis in human glioblastoma cells. When combined with the chemotherapy drug temozolomide, the mushroom extract allowed for lower chemo doses while still killing cancer cells, thanks to its ability to generate oxidative stress and disrupt mitochondrial membranes.